The FDA has begun actively tracking adverse health events linked to hemp and CBD products. This new reporting process marks a step toward greater federal oversight and signals important changes ahead for operators, investors, and consumers.

Cannabis stocks rallied sharply after Donald Trump suggested Medicare could cover CBD in senior healthcare. While no policy has changed, the surge proves how political commentary still drives cannabis markets. Here’s what operators and investors can learn from this moment.

Breaking into New York’s cannabis market is no easy task. Silly Nice shows how quality, transparency, and bold branding can help cannabis businesses stand out and succeed in a crowded space.

Illegal cannabis grows are being shut down across California, highlighting the risks of non-compliance. Learn how licensed operators can protect their business with the right safeguards and insurance coverage.

Cannabis compliance is tightening as federal reform nears. From testing issues to OSHA and cGMP standards, businesses must adopt proactive strategies to stay competitive.